Podcast
Questions and Answers
What is a benefit of using LMWH over unfractionated heparin?
What is a benefit of using LMWH over unfractionated heparin?
- Reduced risk of renal failure
- Lower cost
- More predictable pharmacokinetics (correct)
- Longer half-life
Why is dose adjustment required for LMWH in patients with renal failure?
Why is dose adjustment required for LMWH in patients with renal failure?
- It is excreted by the kidneys (correct)
- It is less effective in renal failure
- It increases the risk of VTHUYTRE
- It has a longer half-life
What did a systematic review and meta-analysis find about preoperative pharmacoprophylaxis and VTE incidence?
What did a systematic review and meta-analysis find about preoperative pharmacoprophylaxis and VTE incidence?
- Increased risk of VTE
- Unpredictable effects on VTE
- No significant impact on VTE incidence
- 40% reduction in the odds of VTE (correct)
What complication is LMWH specifically noted to have reduced compared to unfractionated heparin?
What complication is LMWH specifically noted to have reduced compared to unfractionated heparin?
Why is LMWH the preferred agent of choice in many countries, including the UK?
Why is LMWH the preferred agent of choice in many countries, including the UK?
What is a reason for low-molecular-weight heparin (LMWH) being the preferred agent of choice in many countries, including the UK?
What is a reason for low-molecular-weight heparin (LMWH) being the preferred agent of choice in many countries, including the UK?
What did a systematic review and meta-analysis find about the efficacy of preoperative pharmacoprophylaxis (unfractionated heparin and/or LMWH) on the incidence of VTE following major gynaecologic and gynaecology oncological procedures?
What did a systematic review and meta-analysis find about the efficacy of preoperative pharmacoprophylaxis (unfractionated heparin and/or LMWH) on the incidence of VTE following major gynaecologic and gynaecology oncological procedures?
Why does low-molecular-weight heparin (LMWH) require dose adjustment in patients with renal failure?
Why does low-molecular-weight heparin (LMWH) require dose adjustment in patients with renal failure?
What did a systematic review and meta-analysis find about the efficacy of low-molecular-weight heparin (LMWH) compared to unfractionated heparin in the reduction of VTE?
What did a systematic review and meta-analysis find about the efficacy of low-molecular-weight heparin (LMWH) compared to unfractionated heparin in the reduction of VTE?
What is a benefit of using low-molecular-weight heparin (LMWH) over unfractionated heparin?
What is a benefit of using low-molecular-weight heparin (LMWH) over unfractionated heparin?
Flashcards are hidden until you start studying
